Stay updated on Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial
Sign up to get notified when there's something new on the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page.

Latest updates to the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page
- CheckyesterdayChange DetectedThe record history shows a new revision label of v3.6.2, replacing the previous v3.6.0. This reflects an updated version of the study record.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new entry for Revision: v3.6.0 has been added to the revision history, signaling an updated study record version. The older Revision: v3.5.5 entry has been removed from the history.SummaryDifference0.5%

- Check22 days agoChange DetectedThe revision history now lists the latest release as v3.5.5, replacing the previous v3.5.4.SummaryDifference0.1%

- Check44 days agoChange DetectedThe revision label on the page updated from v3.5.3 to v3.5.4, indicating a new version of the study record history.SummaryDifference0.1%

- Check65 days agoChange DetectedUpdate of the ClinicalTrials.gov page revision indicator from “v3.5.2” to “v3.5.3,” reflecting a platform/version change without altering the study’s recorded content.SummaryDifference0.1%

- Check73 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 in the history.SummaryDifference0.1%

Stay in the know with updates to Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page.